Angiotensin II receptor blockade promotes repair of skeletal muscle through down-regulation of aging-promoting C1q expression

Chizuru Yabumoto,Hiroshi Akazawa,Rie Yamamoto,Masamichi Yano,Yoko Kudo-Sakamoto,Tomokazu Sumida,Takehiro Kamo,Hiroki Yagi,Yu Shimizu,Akiko Saga-Kamo,Atsuhiko T. Naito,Toru Oka,Jong-Kook Lee,Jun-ichi Suzuki,Yasushi Sakata,Etsuko Uejima,Issei Komuro
DOI: https://doi.org/10.1038/srep14453
IF: 4.6
2015-09-25
Scientific Reports
Abstract:Abstract Disruption of angiotensin II type 1 (AT 1 ) receptor prolonged life span in mice. Since aging-related decline in skeletal muscle function was retarded in Atgr1a −/− mice, we examined the role of AT 1 receptor in muscle regeneration after injury. Administration of AT 1 receptor blocker irbesartan increased the size of regenerating myofibers, decreased fibrosis and enhanced functional muscle recovery after cryoinjury. We recently reported that complement C1q, secreted by macrophages, activated Wnt/β-catenin signaling and promoted aging-related decline in regenerative capacity of skeletal muscle. Notably, irbesartan induced M2 polarization of macrophages, but reduced C1q expression in cryoinjured muscles and in cultured macrophage cells. Irbesartan inhibited up-regulation of Axin 2, a downstream gene of Wnt/β-catenin pathway, in cryoinjured muscles. In addition, topical administration of C1q reversed beneficial effects of irbesartan on skeletal muscle regeneration after injury. These results suggest that AT 1 receptor blockade improves muscle repair and regeneration through down-regulation of the aging-promoting C1q-Wnt/β-catenin signaling pathway.
multidisciplinary sciences
What problem does this paper attempt to address?